12 May 2025
12 May 2025
Founded at Israel鈥檚 Sheba Medical Center in 2024, Mentaily has developed LIV in collaboration with Microsoft and KPMG.
The trial will enrol subjects at NewYork-Presbyterian/Weill Cornell Medical Center and four additional sites.
The agency鈥檚 approval was based on the SELF-CERV study of the company.
Paxman and Dignitana provide scalp cooling technologies proven to reduce chemotherapy-induced alopecia.
The device鈥檚 patented vibration technology is said to be validated clinically in a trial to slow the vertebral bone density and strength loss.
The FDA鈥檚 agency-wide genAI rollout is being led by Jeremy Walsh, the recently appointed chief AI officer.
The company stated that it has installed 37 systems, which have been used in over 750 multi-specialty surgeries.
MicroTransponder has posted one-year follow-up data for its FDA-approved device, two months after securing $65m in Series F funds.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
